
Chemical Science p. 2559 - 2574 (2015)
Update date:2022-08-03
Topics:
Chitnis, Saurabh S.
Robertson, Alasdair P. M.
Burford, Neil
Weigand, Jan J.
Fischer, Roland
Reductive elimination of [R3PPR3]2+, [11(R)]2+, from the highly electrophilic SbIII centres in [(R3P)3Sb]3+, [8(R)]3+, gives SbI containing cations [(R3P)Sb]1+, [9(R)]1+, which assemble into frameworks identified as cyclo-tetra(stibinophosphonium) tetracations, [(R3P)4Sb4]4+, [10(R)]4+. A phosphine catalyzed mechanism is proposed for conversion of fluoroantimony complexes [(R3P)2SbF]2+, [7(R)]2+, to [10(R)]4+, and the characterization of key intermediates is presented. The results constitute evidence of a novel ligand activation pathway for phosphines in the coordination sphere of hard, electron deficient acceptors. Characterization of the associated reactants and products supports earlier, albeit less definitive, detection of analogous phosphine ligand activation in CuIII and TlIII complexes, demonstrating that these prototypical ligands can behave simultaneously as reducing agents and σ donors towards a variety of hard acceptors. The reactivity of the parent cyclo-tetra(stibinophosphonium) tetracation, [10(Me)]4+, is directed by high charge concentration and strong polarization of the P-Sb bonds. The former explains the observed facility for reductive elimination to yield elemental antimony and the latter enabled activation of P-Cl and P-H bonds to give phosphinophosphonium cations, [Me3PPR′2]1+, including the first example of an H-phosphinophosphonium, [(Me3P)P(H)R′]1+, and 2-phosphino-1,3-diphosphonium cations, [(Me3P)2PR′]2+. Exchange of a phosphine ligand in [10(Me)]4+ with [nacnac]1- gives [(Me3P)3Sb4(nacnac)]3+, [15(Me)]3+, and with dmap gives [(Me3P)3Sb4(dmap)]4+, [16]4+. The lability of P-Sb or Sb-Sb interactions in [10(Me)]4+ has also been illustrated by characterization of heteroleptically substituted derivatives featuring PMe3 and PEt3 ligands. This journal is
View MoreSEA BRGIHT INDUSTRY CO.,LIMITED
Contact:0086 755 8622 3990
Address:Rm 17B3,GuangCaiXinTianDi Bldg,GuiMiao Rd,NanShan District,Shenzhen,China
Fujian Wanke Pharmaceutical Co., LTD.
Contact:+86-598-5026002
Address:Economic development zone,jiangle county
WUXI HONOR SHINE CHEMICAL CO.,LTD
Contact:+86-510-83593312
Address:No.1699 Huishan avenue,Huishan district,Wuxi ,Jiangsu,China,214177.(Wuxi Huishan Ecomonic Develop Zone )
Contact:86 311 85902108 / 85902109
Address:room 1001-1005 ,huanghe Road ,shijiazhuang ,China
website:http://www.shengmaochem.com
Contact:86-27-82853423, 82819281
Address:Rm 202, A Unit Huaqiao Building No. 2, Lihuangpi Road, Wuhan, China
Doi:10.1016/S0040-4020(01)87328-2
(1986)Doi:10.1021/jo00382a032
(1987)Doi:10.1007/BF00908805
(1964)Doi:10.1248/cpb.c12-00365
(2012)Doi:10.1021/jo01028a016
(1964)Doi:10.1021/jo01035a053
(1964)